Syncom Formulations (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

Profit growth above 25%EBITDA margin expansionRevenue declinedContingent liabilities increasedResults View source PDF Explain this filing

SYNCOMF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.3%Reaction day

₹14.40

prior close

₹14.55

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.5%-1.9% vs market

Pharmaceuticals peers, median of 156sector-0.9%-2.5% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 2.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.0

10m

-4.9

15m

-4.9

30m

-4.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.3-1.5-1.9-0.9-2.5

Next day

-6.7-2.2-4.5-1.4-5.3

-5.3-1.2-4.1-0.9-4.4

-5.6-0.9-4.6-0.5-5.1

-9.1-2.3-6.8-2.0-7.1

-8.3-2.5-5.8-2.2-6.1

-10.2-3.6-6.6-2.8-7.5

15d

-16.7-10.4-6.3-6.9-9.8

-15.8-11.3-4.5-8.6-7.2

-6.9-3.6-3.3-3.4-3.4

-3.8+3.9-7.7+0.9-4.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syncom Formulations reported its Q3 FY26 (Oct–Dec 2025) and nine-month FY26 results along with a clean (unmodified) limited review report from auditors Sanjay Mehta & Associates. Standalone revenue from operations for Q3 came in at Rs. 11,459 lakhs, down about 9.8% from Rs. 12,703 lakhs in Q3 last year, while for the nine months it grew roughly 12% to Rs. 35,257 lakhs (from Rs. 31,439 lakhs). Despite the quarterly revenue dip, profit after tax jumped to Rs. 1,886 lakhs in Q3 (+47% YoY) and Rs. 5,143 lakhs for 9M FY26 (+64% YoY), driven mainly by a sharp fall in raw material costs. EPS for 9M FY26 stood at Rs. 0.61 vs Rs. 0.41 a year ago. The company also disclosed a new GST-related demand of about Rs. 4.42 crore (tax + penalty) which it plans to contest in appeal.

Likely market impact

Strong profit growth and margin expansion are positives for shareholders, but the year-on-year revenue decline in the latest quarter and the fresh Rs. 4.42 crore GST demand (contingent liability) are watch-items that could weigh on the stock. Overall, the results are a mixed bag — better-than-expected profitability but softening top line and a new tax dispute.